These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 22550162

  • 1. Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.
    McBride A, Antonia SJ, Haura EB, Goetz D.
    J Pharm Pract; 2012 Aug; 25(4):477-85. PubMed ID: 22550162
    [Abstract] [Full Text] [Related]

  • 2. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA, Martínez Colmenero C, Peláez Pleguezuelos I, Leiva Gea I, López García AB, de la Cruz Moreno J.
    An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
    [Abstract] [Full Text] [Related]

  • 3. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
    Nowicki TS, Bjornard K, Kudlowitz D, Sandoval C, Jayabose S.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
    [Abstract] [Full Text] [Related]

  • 4. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
    Tuffaha HW, Al Omar S.
    J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
    [Abstract] [Full Text] [Related]

  • 5. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC.
    Cancer; 1995 Aug 01; 76(3):521-6. PubMed ID: 8625136
    [Abstract] [Full Text] [Related]

  • 6. Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.
    Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ.
    Pharmacotherapy; 2010 Jan 01; 30(1):111. PubMed ID: 20030480
    [Abstract] [Full Text] [Related]

  • 7. Solar burn reactivation induced by methotrexate.
    DeVore KJ.
    Pharmacotherapy; 2010 Apr 01; 30(4):123e-6e. PubMed ID: 20334462
    [Abstract] [Full Text] [Related]

  • 8. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC.
    Cancer; 2004 May 15; 100(10):2222-32. PubMed ID: 15139068
    [Abstract] [Full Text] [Related]

  • 9. Effective removal of methotrexate by high-flux hemodialysis.
    Saland JM, Leavey PJ, Bash RO, Hansch E, Arbus GS, Quigley R.
    Pediatr Nephrol; 2002 Oct 15; 17(10):825-9. PubMed ID: 12376811
    [Abstract] [Full Text] [Related]

  • 10. Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.
    Snyder RL.
    Am J Health Syst Pharm; 2007 Jun 01; 64(11):1163-9. PubMed ID: 17519458
    [Abstract] [Full Text] [Related]

  • 11. Low-dose carboxypeptidase-G2 for methotrexate toxicity in a child.
    Qudsi R, Abdulhadi O, Sultan I.
    Pediatr Blood Cancer; 2010 Dec 15; 55(7):1439-40. PubMed ID: 20981700
    [No Abstract] [Full Text] [Related]

  • 12. Potential interaction between methotrexate and omeprazole.
    Beorlegui B, Aldaz A, Ortega A, Aquerreta I, Sierrasesúmega L, Giráldez J.
    Ann Pharmacother; 2000 Sep 15; 34(9):1024-7. PubMed ID: 10981249
    [Abstract] [Full Text] [Related]

  • 13. Optimal management of methotrexate intoxication in a child with osteosarcoma.
    Peyriere H, Cociglio M, Margueritte G, Vallat C, Blayac JP, Hillaire-Buys D.
    Ann Pharmacother; 2004 Mar 15; 38(3):422-7. PubMed ID: 14970366
    [Abstract] [Full Text] [Related]

  • 14. Omeprazole-induced exfoliative dermatitis.
    Rebuck JA, Rybak MJ, Ramos DP, Weingarten CM.
    Pharmacotherapy; 1998 Mar 15; 18(4):877-9. PubMed ID: 9692668
    [Abstract] [Full Text] [Related]

  • 15. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
    Wyatt KD, Cooper J, Scott K, Broomall E, Altaf S, Hogan MC, Rodriguez V, Khan S.
    J Pediatr Hematol Oncol; 2018 Mar 15; 40(2):152-155. PubMed ID: 29240024
    [Abstract] [Full Text] [Related]

  • 16. What is the best therapy for toxicity in the setting of methotrexate-associated acute kidney injury: high-flux hemodialysis or carboxypeptidase G2?
    Kumar N, Shirali AC.
    Semin Dial; 2014 Mar 15; 27(3):226-8. PubMed ID: 24620824
    [No Abstract] [Full Text] [Related]

  • 17. Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.
    Santucci R, Levêque D, Kemmel V, Lutz P, Gérout AC, N'guyen A, Lescoute A, Schneider F, Bergerat JP, Herbrecht R.
    Anticancer Res; 2010 Mar 15; 30(3):963-5. PubMed ID: 20393020
    [Abstract] [Full Text] [Related]

  • 18. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ, Lee J, Oguro T, Petrilli AS, Bordin JO.
    Am J Hematol; 2003 Mar 15; 72(3):209-11. PubMed ID: 12605394
    [Abstract] [Full Text] [Related]

  • 19. Intramuscular methotrexate-induced aseptic meningitis.
    Hawboldt J, Bader M.
    Ann Pharmacother; 2007 Nov 15; 41(11):1906-11. PubMed ID: 17878395
    [Abstract] [Full Text] [Related]

  • 20. Preventing and Managing Toxicities of High-Dose Methotrexate.
    Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD.
    Oncologist; 2016 Dec 15; 21(12):1471-1482. PubMed ID: 27496039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.